Superseded · version 1: Cagrilintide^↗

Related names recorded in this version: AM833^↗

A long-acting amylin analogue represented in ongoing ClinicalTrials.gov records.^↗

This is preserved historical wording.
It is no longer the current profile. Read the current profile and its correction notice.

What this version reported

ClinicalTrials.gov lists a Novo Nordisk pediatric study as recruiting, updated July 17, 2026.^↗

Organizations named in cited records:

Trial records: NCT07253285